Page 387 - Veterinary Toxicology, Basic and Clinical Principles, 3rd Edition

354 SECTION | III Nanoparticles, Radiation and Carcinogens

VetBooks.ir understand the biological and molecular underpinnings of Lee, S.J., Yum, Y.N., Kim, S.C., Kim, Y., Lim, J., et al., 2013.
Distinguishing between genotoxic and non-genotoxic hepatocarcino-
carcinogenesis. Nevertheless, the accumulated knowledge
gens by gene expression profiling and bioinformatic pathway analy-
on various aspects of carcinogenesis has definitely helped
scientists conduct appropriate risk assessment that lead to sis. Sci. Rep. 3, 2783.
Marquardt, H., 1999. Chemical carcinogenesis. In: Marquardt, H.,
health policy recommendations. One arena of risk assess-
Scha ¨fer, S.G., McClellan, R.O., Welsch, F. (Eds.), Toxicology.
ment that is still under development is the extent to which
Academic Press, San Diego, CA, pp. 151 178.
a threshold can be determined for a genotoxic carcinogen.
Moore, P.S., Chang, Y., 2010. Why do viruses cause cancer? Highlights
Finally, recent progress in the science of genomics has
of the first century of human tumor virology. Nat. Rev. Cancer. 10,
provided scientists and clinicians alike with renewed hope 878 889.
that further breakthroughs in understanding carcinogene- Nordling, C.O., 1953. A new theory on cancer-inducing mechanism. Br.
sis and cancer detection will lead to new therapies that J. Cancer. 7, 68 72.
will allow us to effectively control the disease. Okey, A.B., Harper, P.A., Grant, D.M., Hill, R.P., 1998. Chemical and
radiation carcinogenesis. In: Tannock, I.F., Hill, R.P. (Eds.), The
Basic Science of Oncology, third ed. McGraw-Hill, New York,
pp. 166 196.
REFERENCES
Pitot, H.C., 2002. Fundamentals of Oncology. fourth ed. Marcel and
Adams, G.E., Cox, R., 1997. Radiation carcinogenesis. In: Franks, L.M., Dekker, Inc., New York.
Teich, N.M. (Eds.), Cellular and Molecular Biology of Cancer, third Pogribny, I.P., Rusyn, I., Beland, F.A., 2008. Epigenetic aspects of geno-
ed. Oxford University Press, Oxford, pp. 130 150. toxic and non-genotoxic hepatocarcinogenesis: studies in rodents.
Armitage, P., Doll, R., 1954. The age distribution of cancer and a multi- Environ. Mol. Mutagen. 49, 9 15.
stage theory of carcinogenesis. Br. J. Cancer. 8, 1 12. Qin, X., Zhang, S., Matsukuma, S., Zarkovic, M., Shimizu, S., Ishikawa,
Becker, K., Gregel, C., Fricke, C., Komitowski, D., Dosch, J., Kaina, B., T., et al., 2000. Protection against malignant progression of sponta-
2003. DNA repair protein MGMT protects against N-methyl-N- neously developing liver tumors in transgenic mice expressing
6
nitrosourea-induced conversion of benign into malignant tumors. O -methylguanine-DNA methyltransferase. Jpn. J. Cancer Res. 91,
Carcinogenesis. 24, 541 546. 1085 1089.
Benigni, R., Bossa, C., Tcheremenskaia, O., 2013. Nongenotoxic carci- Sharma, S., Kelly, T.K., Jones, P.A., 2010. Epigenetics in cancer.
nogenicity of chemicals: mechanisms of action and early recognition Carcinogenesis. 31, 27 36.
through a new set of structural alerts. Chem. Rev. 113, 2940 2957. Smela, M.E., Currier, S.S., Bailey, E.A., Essigmann, J.M., 2001. The
Berenblum, I., Shubik, P., 1947. A new, quantitative, approach to the chemistry and biology of aflatoxin B(1): from mutational spectrome-
study of the stages of chemical carcinogenesis in the mouse’s skin. try to carcinogenesis. Carcinogenesis. 22, 535 545.
Br. J. Cancer. 1, 383 391. Spitz, D.R., Azzam, E.I., Li, J.J., Gius, D., 2004. Metabolic oxidation/
Butel, J.S., 2000. Viral carcinogenesis: revelation of molecular mechan- reduction reactions and cellular responses to ionizing radiation: a
unifying concept in stress response biology. Cancer Metas. Rev. 23,
isms and etiology of human disease. Carcinogenesis. 21, 405 426.
311 322.
Choudhuri, S., Arvidson, K., Chanderbhan, R., 2012. Carcinogenesis:
Stsjazhko, V.A., Tsyb, A.F., Tronko, N.D., Souchkevitch, G.,
mechanisms and models. In: Gupta, R.C. (Ed.), Veterinary
Baverstock, K.F., 1995. Childhood thyroid cancer since accident at
Toxicology, second ed. Academic Press, Oxford, pp. 406 425.
Chernobyl. Br.Med. J. 310, 801.
Cooper, G.M., 1995. Oncogenes. second ed. Jones and Bartlett, Boston,
Takeya, T., Hanafusa, H., 1983. Structure and sequence of the cellular
MA.
gene homologous to the RSV src gene and the mechanism for gener-
Dipple, A., 1995. DNA adducts of chemical carcinogens.
ating the transforming virus. Cell. 32, 881 890.
Carcinogenesis. 16, 437 441.
Tennant, R., 1999. What is a tumor promoter? Environ. Hlth. Perspec.
Foulds, L., 1954. The experimental study of tumor progression: a review.
Cancer Res. 14, 327 339. 107, A390 A391.
Irigaray, P., Belpomme, D., 2010. Basic properties and molecular Trosko, J.E., Upham, B.L., 2005. The emperor wears no clothes in the
mechanisms of exogenous chemical carcinogens. Carcinogenesis. field of carcinogen risk assessment: ignored concepts in cancer risk
31, 135 148. assessment. Mutagenesis. 20, 81 92.
Jones, P.A., Baylin, S.B., 2007. The epigenomics of cancer. Cell. 128, Wu, L.J., Randers-Pehrson, G., Xu, A., Waldren, C.A., Geard, C.R., Yu,
683 692. Z., et al., 1999. Targeted Cytoplasmic Irradiation with Alpha
Knudson Jr., A.G., 1971. Mutation and cancer: statistical study of retino- Particles Induces Mutations in Mammalian Cells. Proc. Natl. Acad.
blastoma. Proc. Natl. Acad. Sci. USA. 68, 820 823. Sci. USA. 96, 4959 4964.